Last reviewed · How we verify
Intravenous Lipid Emulsion
Intravenous Lipid Emulsion is a Small molecule drug developed by Stanley Dudrick's Memorial Hospital. It is currently FDA-approved. Also known as: Intralipid, ATC: B05BA02.
At a glance
| Generic name | Intravenous Lipid Emulsion |
|---|---|
| Also known as | Intralipid, ATC: B05BA02 |
| Sponsor | Stanley Dudrick's Memorial Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Lipid Emulsions on Coagulation
- Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients (PHASE2)
- Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses (PHASE2)
- Does Intralipid Infusion Can Reverse the Spinal Anesthesia Effect in Day Case Surgery? (NA)
- Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients (PHASE4)
- Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration (PHASE2)
- Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation. (PHASE1, PHASE2)
- A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous Lipid Emulsion CI brief — competitive landscape report
- Intravenous Lipid Emulsion updates RSS · CI watch RSS
- Stanley Dudrick's Memorial Hospital portfolio CI
Frequently asked questions about Intravenous Lipid Emulsion
What is Intravenous Lipid Emulsion?
Intravenous Lipid Emulsion is a Small molecule drug developed by Stanley Dudrick's Memorial Hospital.
Who makes Intravenous Lipid Emulsion?
Intravenous Lipid Emulsion is developed and marketed by Stanley Dudrick's Memorial Hospital (see full Stanley Dudrick's Memorial Hospital pipeline at /company/stanley-dudrick-s-memorial-hospital).
Is Intravenous Lipid Emulsion also known as anything else?
Intravenous Lipid Emulsion is also known as Intralipid, ATC: B05BA02.
What development phase is Intravenous Lipid Emulsion in?
Intravenous Lipid Emulsion is FDA-approved (marketed).
Related
- Manufacturer: Stanley Dudrick's Memorial Hospital — full pipeline
- Also known as: Intralipid, ATC: B05BA02
- Compare: Intravenous Lipid Emulsion vs similar drugs
- Pricing: Intravenous Lipid Emulsion cost, discount & access